ERFE and sarcopenia: To evaluate the effect of myonectin on age-associated sarcopenia, senescence accelerated mouse prone (SAMP) 8 mice, which display a phenotype of accelerated aging, were subjected to intramuscular administration of Ad-myonectin or control Ad-β-gal at the age of 33 weeks.